OraSure Technologies, Inc. engages in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices. It operates through the following segments: OraSure and DNAG. The OraSure segment consists of the development, manufacture, and sale of diagnostic products, specimen collection devices, and medical devices. The DNAG segment offers development, manufacture, and sale of oral fluid collection devices that are used to collect, stabilize, and store samples of genetic material for molecular testing. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.
